Table 2: Therapeutic response in the two groups at day 42.
AS + AQ, artesunate + amodiaquine; AL, artemether–lumefantrine. P values were obtained by Fisher’s exact test.
| Outcome | ASAQ (%) | AL (%) | p-value |
| IIT Analysis |
| Enrolled patients | 120 | 121 | |
| Patients seen | 118/120 (98.3) | 116/121 (95.9) | 0.44 |
| Missing | 02/120 (1.7) | 05/121 (4.1) | 0.44 |
| Crude failure rate | 07/120 (5.8) | 19/121 (15.7) | 0.05 |
| Crude cure rate | 113/120 (94.2) | 102/121 (84.3) | 0,17 |
| PCR adjusted failure rate | 03/120 (2.5) | 8/121 (6.6) | 0.22 |
| PCR adjusted ACPR | 115/120 (97.5) | 113/121 (93.4) | 0.57 |
| PP Analysis |
| Patients seen | 118 | 116 | |
| Crude failure rate | 05/118 (4.20) | 14/116 (12.1) | 0.05 |
| Crude cure rate | 113/118 (95.8) | 102/116 (87.9) | 0.05 |
| PCR adjusted failure rate | 01/118 (0.8) | 03/116 (2.6) | 0.60 |
| PCR adjusted ACPR | 117/118 (99.2) | 113/116 (97.4) | 0.60 |